首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes
【24h】

Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

机译:在诊断代码不可用时识别牛皮癣和银屑病关节炎患者:诊断代码:验证研究比较药物/处方基于诊断码的算法

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Using diagnosis code–based algorithms is the primary method of identifying patient cohorts for retrospective studies; nevertheless, many databases lack reliable diagnosis code information. Objectives To develop precise algorithms based on medication claims/prescriber visits (MCs/PVs) to identify psoriasis (PsO) patients and psoriatic patients with arthritic conditions (PsO-AC), a proxy for psoriatic arthritis, in Canadian databases lacking diagnosis codes. Methods Algorithms were developed using medications with narrow indication profiles in combination with prescriber specialty to define PsO and PsO-AC. For a 3-year study period from July 1, 2009, algorithms were validated using the PharMetrics Plus database, which contains both adjudicated medication claims and diagnosis codes. Positive predictive value (PPV), negative predictive value (NPV), sensitivity, and specificity of the developed algorithms were assessed using diagnosis code as the reference standard. Chosen algorithms were then applied to Canadian drug databases to profile the algorithm-identified PsO and PsO-AC cohorts. Results In the selected database, 183,328 patients were identified for validation. The highest PPVs for PsO (85%) and PsO-AC (65%) occurred when a predictive algorithm of two or more MCs/PVs was compared with the reference standard of one or more diagnosis codes. NPV and specificity were high (99%–100%), whereas sensitivity was low (≤30%). Reducing the number of MCs/PVs or increasing diagnosis claims decreased the algorithms’ PPVs. Conclusions We have developed an MC/PV-based algorithm to identify PsO patients with a high degree of accuracy, but accuracy for PsO-AC requires further investigation. Such methods allow researchers to conduct retrospective studies in databases in which diagnosis codes are absent.
机译:抽象背景使用基于诊断码的算法是识别回顾性研究的患者群组的主要方法;然而,许多数据库缺乏可靠的诊断码信息。基于药物索赔/旁观票据(MCS / PVS)来开发精确算法的目标,以鉴定牛皮癣(PSO)患者和有关节炎条件(PSO-AC)的患者,在加拿大数据库中缺乏诊断代码的基金会关节炎的代理。方法使用具有窄指示曲线的药物和PERCRBER专业结合使用缩小指示曲线来开发算法以定义PSO和PSO-AC。对于2009年7月1日的3年度的研究期,使用药物和数据库进行验证算法,该数据库包含判决药物索赔和诊断代码。使用诊断码作为参考标准评估发达算法的阳性预测值(PPV),否定预测值(NPV),灵敏度和特异性。然后将所选择的算法应用于加拿大药物数据库,以简要算法识别的PSO和PSO-AC队列。结果在所选数据库中,确定了183,328名患者进行验证。当与一个或多个诊断码的参考标准进行比较了两个或多个MCS / PVS的预测算法时,PSO(85%)和PSO-AC(65%)的最高PPV。 NPV和特异性高(99%-100%),而敏感性低(≤30%)。减少MCS / PVS的数量或增加诊断声明减少了算法的PPV。结论我们开发了一种基于MC / PV的算法,可以识别具有高精度的PSO患者,但PSO-AC的准确性需要进一步调查。这些方法允许研究人员在诊断码不存在的数据库中进行回顾性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号